The Standard

Document defines precision medicine use cases, supporting underlying
foundations for genomics in FHIR

This week, we published the HL7 Domain Analysis Model: Clinical Genomics after a rigorous ISO/ANSI-compatible balloting process. The document is part of an ongoing effort by the HL7 Clinical Genomics Work Group to identify common workflows and use cases to facilitate scalable and interoperable data standards for the breadth of clinical genomics scenarios. The Domain Analysis Model (DAM) is becoming a widely used reference for clinical genomics, covering a myriad of use cases, including emerging ones such as preimplantation genetic diagnosis, whole exome sequencing, RNA-sequencing and proteomics.

As the global authority for interoperability in health care information technology with affiliates in 35 countries, we're excited to announce the publication of Release 4 of the HL7 Fast Healthcare Interoperability Resources (FHIR^®) standard. This new version is the culmination of 18 months of extensive work to finalize the base parts of the specification and incorporates changes and enhancement requests received from implementation partners around the world.

"HL7 FHIR R4 is a beginning," said HL7 CEO Dr. Charles Jaffe. "It is the legacy of eight years of innovation and collaboration among a community of thousands around the world. It is a commitment from HL7 to create a platform from which Interoperability can someday emerge. It is a promise to provide reusable data across the continuum of biomedical research, patient care, and population health."

New to Confluence? We've got you covered.